Labcorp Holdings Inc (LH) has declared a quarterly dividend of $0.72 per share, payable to shareholders of record. This announcement highlights the company’s commitment to returning value to its investors.
The dividend will be paid on December 10, 2025, to shareholders who own shares before the ex-dividend date of November 25, 2025. The current dividend yield stands at 1.09%, reflecting the annual dividend income relative to the stock price.
Labcorp operates in the health care industry, providing laboratory services that assist doctors, hospitals, and researchers in making informed decisions. The company, headquartered in Burlington, North Carolina, employs approximately 70,000 full-time staff and operates through two primary segments: Diagnostics Laboratories and Biopharma Laboratory Services. The Diagnostics segment includes routine and specialty testing, while the Biopharma division focuses on early development research and central laboratory services.
The firm’s market capitalization is $21.6 billion, with a price-to-earnings (P/E) ratio of 25.26 and earnings per share (EPS) of 10.18. Upcoming earnings are scheduled for July 22, 2026, with an EPS estimate of $4.78 and revenue expected to reach $3.8 billion.
Such decisions reflect Labcorp’s ongoing strategy to provide regular income to shareholders, reinforcing its position in the market. Investors may consider reviewing the company's dividend history, payout ratio, and financial health when evaluating the sustainability of these payments.